Pharmaceutical Technology-05-02-2019

Pharmaceutical Technology

New Pneumatic Presses

May 02, 2019

Product Spotlight

43

5

Wabash MPI and Carver’s PNP Series is a new line of pneumatic presses for a variety of applications, including composites molding, laminating, rubber molding, plastics testing, fluid/resin extraction, destructive testing, bonding, cell disruption, and sample preparation.

Bioprocessing Facilities and FDA Inspection Problems

May 02, 2019

Features

43

5

FDA inspections can create uncertainty. Supervision of the contract manufacturer is crucial in ensuring compliance.

FDA Faces Challenges After Gottlieb

May 02, 2019

Regulatory Watch

43

5

New agency leadership is pressed to promote innovation while addressing safety and quality issues.

The Auditor Vs. Inspector Issue

May 02, 2019

Ask the Expert

43

5

We need to understand both sides when it comes to audits, says Siegfried Schmitt, PhD, vice-president, technical, PAREXEL Consulting.

Working for the Greater Good

May 02, 2019

From the Editor

43

5

Pharma delivers a positive message with renewed efforts to eradicate malaria.

Getting a Handle on Biopharm’s Most Critical Quality Attributes

May 02, 2019

Features

43

5

While the multiple attributes method gains ground and traditional lab methods improve, broad efforts are underway to determine biopharmaceuticals’ most significant critical quality attributes and enable real-time release.

Testing for Water in DMSO: Exploring Alternatives to Volumetric Karl Fischer Analysis

May 02, 2019

Peer-Reviewed Research

43

5

In Karl Fischer analysis, sulfur trioxide can react with DMSO, invalidating test results. The authors evaluated different instruments and methods, described in this article, to minimize the impact on results.

Pharmaceutical Technology North America, May 2019 (PDF)

May 02, 2019

Issue PDF

43

5

Click the title above to open the Pharmaceutical Technology May 2019 issue in an interactive PDF format.

Playing the Waiting Game with GMP Guideline Revisions

May 01, 2019

Regulatory Watch

43

5

Delays in revisions to guidelines by the European Union are impeding the pharmaceutical industry.

Broadening Europe’s Research Horizons

May 01, 2019

From the Editor

43

5

Horizon Europe gains parliamentary endorsement, bringing it closer to becoming a reality.